Proteomic analysis of differential protein expression in primary hepatocytes induced by EGF, tumour necrosis factor α or the peroxisome proliferator nafenopin

European Journal of Biochemistry

Volumn 267, Issue 15, 2000, Pages 4624-4634

  Chevalier, Stephan ^a   Macdonald, Neil ^a   Tonge, Robert ^a   Rayner, Steve ^a   Rowlinson, Rachel ^a   Shaw, Joanne ^a   Young, Janice ^a   Davison, Matthew ^a   Roberts, Ruth A ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

Epidermal growth factor; Hepatocyte; Peroxisome proliferator; Proteome; Tumour necrosis factor

Indexed keywords

EPIDERMAL GROWTH FACTOR; MUSCARINIC M3 RECEPTOR; NAFENOPIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA; VIMENTIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; LIVER CELL; MALE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ACTINS; ANIMALS; CELLS, CULTURED; DATABASES, FACTUAL; DIMETHYLFORMAMIDE; DNA REPLICATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION; IMAGE PROCESSING, COMPUTER-ASSISTED; ISOELECTRIC FOCUSING; LIVER; MASS SPECTROMETRY; NAFENOPIN; OXIDATIVE STRESS; PEROXISOME PROLIFERATORS; PROTEOME; RATS; RECEPTORS, MUSCARINIC; SIGNAL TRANSDUCTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; VIMENTIN;

EID: 0033856330     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.2000.01487.x     Document Type: Article

References (43)

1. Perturbation of rodent hepatocyte growth control by non-genotoxic hepatocarcinogens: Mechanisms and lack of relevance for human health
2. Mechanism of action of the nongenotoxic peroxisome proliferators: Role of the peroxisome proliferator-activator receptor
3. Peroxisome proliferator-activated receptor: Nuclear control of metabolism
4. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
5. Extraperoxisomal targets of peroxisome proliferators: Mitochondrial, microsomal and cytosolic effects. Implications for health and disease
6. Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleitrophic effects of peroxisome proliferators
7. Role of PPARα in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator, Wy-14,643
8. 2D protein electrophoresis: Can it be perfected?
9. Proteomics in drug discovery
10. The effects of peroxisome proliferators on protein abundances in mouse liver
11. A proteome analysis of livers from obese (ob/ob) mice treated with the peroxisome proliferator Wy14,643
12. Cytokines in non-genotoxic hepatocarcinogenesis
13. Role of Kupffer cells in peroxisome proliferator-induced hepatocyte proliferation
14. Changes in protein and mRNA levels of growth factor/growth factor receptors in rat livers after administration of phenobarbitone or methylclofenapate
15. Induction of DNA replication by peroxisome proliferators is independent of both tumour necrosis factor α priming and EGF-receptor tyrosine kinase activity
16. Tumor necrosis factor primes hepatocytes for DNA replication in the rat
17. Role for tumour necrosis factor α receptor 1 and interleukin-1 receptor in the suppression of mouse hepatocyte apoptosis by the peroxisome proliferator nafenopin
18. Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than with suppression of apoptosis
19. Mass spectrometric sequencing of proteins from silver-stained polyacryl amide gels
20. G1-arrested FaO cells re-enter the cell cycle upon stimulation with the rodent nongenotoxic hepatocarcinogen nafenopin
21. Specific changes in the protein composition of rat liver in response to the peroxisome proliferators ciprofibrate, Wy-14,643 and di-(2-ethylhexyl)phthalate
22. Modification of hepatic immunogl0bulih heavy chain binding protein (BiP/Grp78) following exposure to structurally diverse peroxisome proliferators
23. A comparison of liver protein changes in mice and hamsters treated with the peroxisome proliferator Wy-14,643
24. Rosiglitazone (BRL49653), a PPARγ-selective agonist, causes peroxisome proliferator-like liver effects in obese mice
25. Tumour necrosis factor α (TNF-α) suppresses apoptosis and induces DNA synthesis in rodent hepatocytes: A mediator of the hepatocarcinogenicity of peroxisome proliferators?
26. Actin cleavage by CPP-32/apopain during the development of apoptosis
27. Coexpression of a mutant beta-actin and the two normal beta- and gamma-cytoplasmic actins in a stably transformed cell line
28. Delta 3,5-delta 2,4-dienoyl-CoA isomerase from rat liver. Molecular characterization
29. Identification of peroxisomal protein by using M13 phage protein VI phage display: Molecular evidence that mammalian peroxisomes contain a 2,4-dienoyl-CoA reductase
30. Mode of action of peroxisome proliferators as hypolipidemic drugs
31. Induction of adipose conversion in 3T3-L1 cells is associated with an early phosphorylation of a protein partly homologous with mouse vimentin
32. Effect of phthalate esters on energy coupling and succinate oxidation in rat liver mitochondria
33. Ethylhexanol uncouples oxidative phosphorylation in rat liver mitochondria
34. Inhibition of mitochondrial respiration and oxygen-dependent hepatotoxicity by six structurally dissimilar peroxisomal proliferating agents
35. The nongenotoxic hepatocarcinogen Wy-14,643 is an uncoupler of oxidative phosphorylation in vivo
36. In vitro effects of eight-carbon fatty acids on oxidation in rat liver mitochondria
37. Mitochondrial oxidative phosphorylation and intracellular glutathione compartmentation during rat liver regeneration
38. Oligomerization properties of erp29, an endoplasmic reticulum stress protein
39. Rat liver BiP/GRP78 is down-regulated by a peroxisome proliferator, clofibrate
40. Regulatory role for a novel human thioredoxin peroxidase in NF-kB activation
41. Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumour necrosis factor
42. Oxidative stress oppositely modulates protein tyrosine phosphorylation stimulated by muscarinic G protein-coupled and epidermal growth factor receptors